Benitec Biopharma Inc. · NASDAQ:BNTC

Montanova Capital, LLC reported a 49.90% stake in Benitec Biopharma Inc. (Schedule 13D/A)

Event Mar 26, 2025 · Filed Mar 28, 2025

Montanova Capital, LLC reported a 49.90% stake in Benitec Biopharma Inc., 15,623,659 shares, with active intent on Mar 26, 2025. Filed Mar 28, 2025 (Schedule 13D/A).

Stake
49.90%
Shares
15,623,659
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
SUVRETTA CAPITAL MANAGEMENT, LLC49.90%15,623,659
Averill Master Fund, Ltd.44.47%13,922,844
Averill Madison Master Fund, Ltd.5.43%1,700,815
Aaron Cowen49.90%15,623,659

Source

View original at SEC

Related